nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ACHE—prostate cancer	0.484	0.664	CbGaD
Ephedrine—ADRB2—prostate cancer	0.245	0.336	CbGaD
Ephedrine—ACHE—prostate gland—prostate cancer	0.000783	0.147	CbGeAlD
Ephedrine—Pseudoephedrine—IL2—prostate cancer	0.000777	0.178	CrCbGaD
Ephedrine—SLC18A2—prostate gland—prostate cancer	0.000763	0.143	CbGeAlD
Ephedrine—Etomidate—CYP19A1—prostate cancer	0.000471	0.108	CrCbGaD
Ephedrine—ADRA1A—prostate gland—prostate cancer	0.000433	0.0814	CbGeAlD
Ephedrine—Amphetamine—SLC22A3—prostate cancer	0.000412	0.0946	CrCbGaD
Ephedrine—BCHE—prostate gland—prostate cancer	0.000385	0.0723	CbGeAlD
Ephedrine—Methamphetamine—SLC22A3—prostate cancer	0.000382	0.0877	CrCbGaD
Ephedrine—ACHE—testis—prostate cancer	0.000345	0.0648	CbGeAlD
Ephedrine—SLC18A2—testis—prostate cancer	0.000336	0.0632	CbGeAlD
Ephedrine—BCHE—seminal vesicle—prostate cancer	0.000325	0.0612	CbGeAlD
Ephedrine—Urinary retention—Capecitabine—prostate cancer	0.000321	0.00195	CcSEcCtD
Ephedrine—Anorexia—Goserelin—prostate cancer	0.00032	0.00194	CcSEcCtD
Ephedrine—Tension—Estradiol—prostate cancer	0.00032	0.00194	CcSEcCtD
Ephedrine—Dizziness—Bicalutamide—prostate cancer	0.000319	0.00193	CcSEcCtD
Ephedrine—ADRA1A—epithelium—prostate cancer	0.000318	0.0598	CbGeAlD
Ephedrine—Anorexia—Conjugated Estrogens—prostate cancer	0.000317	0.00192	CcSEcCtD
Ephedrine—Nervousness—Estradiol—prostate cancer	0.000316	0.00192	CcSEcCtD
Ephedrine—Muscle spasms—Estradiol—prostate cancer	0.000313	0.0019	CcSEcCtD
Ephedrine—Arrhythmia—Mitoxantrone—prostate cancer	0.000312	0.00189	CcSEcCtD
Ephedrine—Vomiting—Bicalutamide—prostate cancer	0.000307	0.00186	CcSEcCtD
Ephedrine—Tremor—Estradiol—prostate cancer	0.000305	0.00185	CcSEcCtD
Ephedrine—Rash—Bicalutamide—prostate cancer	0.000304	0.00184	CcSEcCtD
Ephedrine—Dermatitis—Bicalutamide—prostate cancer	0.000304	0.00184	CcSEcCtD
Ephedrine—Insomnia—Goserelin—prostate cancer	0.000303	0.00184	CcSEcCtD
Ephedrine—Headache—Bicalutamide—prostate cancer	0.000302	0.00183	CcSEcCtD
Ephedrine—Insomnia—Conjugated Estrogens—prostate cancer	0.0003	0.00182	CcSEcCtD
Ephedrine—Agitation—Estradiol—prostate cancer	0.000299	0.00182	CcSEcCtD
Ephedrine—Dyspnoea—Goserelin—prostate cancer	0.000299	0.00181	CcSEcCtD
Ephedrine—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000296	0.0018	CcSEcCtD
Ephedrine—Dyspepsia—Goserelin—prostate cancer	0.000295	0.00179	CcSEcCtD
Ephedrine—ADRA1A—renal system—prostate cancer	0.000295	0.0554	CbGeAlD
Ephedrine—Psychotic disorder—Prednisone—prostate cancer	0.000293	0.00178	CcSEcCtD
Ephedrine—Angina pectoris—Docetaxel—prostate cancer	0.000293	0.00178	CcSEcCtD
Ephedrine—Vertigo—Estradiol—prostate cancer	0.000293	0.00178	CcSEcCtD
Ephedrine—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000292	0.00177	CcSEcCtD
Ephedrine—Asthenia—Ethinyl Estradiol—prostate cancer	0.000292	0.00177	CcSEcCtD
Ephedrine—Decreased appetite—Goserelin—prostate cancer	0.000292	0.00177	CcSEcCtD
Ephedrine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000289	0.00175	CcSEcCtD
Ephedrine—Palpitations—Estradiol—prostate cancer	0.000288	0.00175	CcSEcCtD
Ephedrine—Irritability—Prednisone—prostate cancer	0.000287	0.00174	CcSEcCtD
Ephedrine—Pain—Goserelin—prostate cancer	0.000287	0.00174	CcSEcCtD
Ephedrine—Nausea—Bicalutamide—prostate cancer	0.000286	0.00174	CcSEcCtD
Ephedrine—Pain—Conjugated Estrogens—prostate cancer	0.000284	0.00172	CcSEcCtD
Ephedrine—Angina pectoris—Capecitabine—prostate cancer	0.000284	0.00172	CcSEcCtD
Ephedrine—Hypertension—Estradiol—prostate cancer	0.000281	0.00171	CcSEcCtD
Ephedrine—Selegiline—CYP2A6—prostate cancer	0.000278	0.0638	CrCbGaD
Ephedrine—Chest pain—Estradiol—prostate cancer	0.000277	0.00168	CcSEcCtD
Ephedrine—Anxiety—Estradiol—prostate cancer	0.000276	0.00168	CcSEcCtD
Ephedrine—Feeling abnormal—Goserelin—prostate cancer	0.000276	0.00168	CcSEcCtD
Ephedrine—Phenylpropanolamine—ADRB2—prostate cancer	0.000275	0.0632	CrCbGaD
Ephedrine—Dysuria—Capecitabine—prostate cancer	0.000273	0.00165	CcSEcCtD
Ephedrine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000269	0.00163	CcSEcCtD
Ephedrine—Confusional state—Estradiol—prostate cancer	0.000268	0.00163	CcSEcCtD
Ephedrine—Body temperature increased—Goserelin—prostate cancer	0.000265	0.00161	CcSEcCtD
Ephedrine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000263	0.00159	CcSEcCtD
Ephedrine—Hypertension—Mitoxantrone—prostate cancer	0.000262	0.00159	CcSEcCtD
Ephedrine—Tachycardia—Estradiol—prostate cancer	0.000259	0.00157	CcSEcCtD
Ephedrine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000259	0.00157	CcSEcCtD
Ephedrine—Chest pain—Mitoxantrone—prostate cancer	0.000258	0.00157	CcSEcCtD
Ephedrine—Anxiety—Mitoxantrone—prostate cancer	0.000258	0.00156	CcSEcCtD
Ephedrine—Hyperhidrosis—Estradiol—prostate cancer	0.000257	0.00156	CcSEcCtD
Ephedrine—Rash—Ethinyl Estradiol—prostate cancer	0.000257	0.00156	CcSEcCtD
Ephedrine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000257	0.00156	CcSEcCtD
Ephedrine—Headache—Ethinyl Estradiol—prostate cancer	0.000255	0.00155	CcSEcCtD
Ephedrine—ACHE—lymph node—prostate cancer	0.00025	0.047	CbGeAlD
Ephedrine—Confusional state—Mitoxantrone—prostate cancer	0.00025	0.00151	CcSEcCtD
Ephedrine—SLC18A2—lymph node—prostate cancer	0.000244	0.0458	CbGeAlD
Ephedrine—Muscle spasms—Etoposide—prostate cancer	0.000243	0.00147	CcSEcCtD
Ephedrine—Nausea—Ethinyl Estradiol—prostate cancer	0.000242	0.00147	CcSEcCtD
Ephedrine—Tachycardia—Mitoxantrone—prostate cancer	0.000242	0.00147	CcSEcCtD
Ephedrine—Asthenia—Goserelin—prostate cancer	0.000241	0.00146	CcSEcCtD
Ephedrine—Insomnia—Estradiol—prostate cancer	0.00024	0.00146	CcSEcCtD
Ephedrine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000239	0.00145	CcSEcCtD
Ephedrine—Asthenia—Conjugated Estrogens—prostate cancer	0.000238	0.00145	CcSEcCtD
Ephedrine—Bradycardia—Capecitabine—prostate cancer	0.000238	0.00144	CcSEcCtD
Ephedrine—Dyspnoea—Estradiol—prostate cancer	0.000237	0.00144	CcSEcCtD
Ephedrine—Anorexia—Mitoxantrone—prostate cancer	0.000236	0.00143	CcSEcCtD
Ephedrine—Dyspepsia—Estradiol—prostate cancer	0.000234	0.00142	CcSEcCtD
Ephedrine—Pseudoephedrine—ADRB2—prostate cancer	0.000232	0.0534	CrCbGaD
Ephedrine—Decreased appetite—Estradiol—prostate cancer	0.000231	0.0014	CcSEcCtD
Ephedrine—Amphetamine—CYP2A6—prostate cancer	0.000231	0.053	CrCbGaD
Ephedrine—Pain—Estradiol—prostate cancer	0.000227	0.00138	CcSEcCtD
Ephedrine—Vertigo—Etoposide—prostate cancer	0.000227	0.00138	CcSEcCtD
Ephedrine—Dizziness—Goserelin—prostate cancer	0.000222	0.00135	CcSEcCtD
Ephedrine—Dyspnoea—Mitoxantrone—prostate cancer	0.000221	0.00134	CcSEcCtD
Ephedrine—Dizziness—Conjugated Estrogens—prostate cancer	0.00022	0.00133	CcSEcCtD
Ephedrine—Feeling abnormal—Estradiol—prostate cancer	0.000219	0.00133	CcSEcCtD
Ephedrine—Dyspepsia—Mitoxantrone—prostate cancer	0.000218	0.00132	CcSEcCtD
Ephedrine—Hypertension—Etoposide—prostate cancer	0.000218	0.00132	CcSEcCtD
Ephedrine—Decreased appetite—Mitoxantrone—prostate cancer	0.000215	0.00131	CcSEcCtD
Ephedrine—Arrhythmia—Docetaxel—prostate cancer	0.000215	0.00131	CcSEcCtD
Ephedrine—Chest pain—Etoposide—prostate cancer	0.000215	0.0013	CcSEcCtD
Ephedrine—Vomiting—Goserelin—prostate cancer	0.000213	0.00129	CcSEcCtD
Ephedrine—Pain—Mitoxantrone—prostate cancer	0.000212	0.00128	CcSEcCtD
Ephedrine—Bradycardia—Prednisone—prostate cancer	0.000212	0.00128	CcSEcCtD
Ephedrine—Rash—Goserelin—prostate cancer	0.000211	0.00128	CcSEcCtD
Ephedrine—Dermatitis—Goserelin—prostate cancer	0.000211	0.00128	CcSEcCtD
Ephedrine—Vomiting—Conjugated Estrogens—prostate cancer	0.000211	0.00128	CcSEcCtD
Ephedrine—Body temperature increased—Estradiol—prostate cancer	0.00021	0.00127	CcSEcCtD
Ephedrine—Headache—Goserelin—prostate cancer	0.00021	0.00127	CcSEcCtD
Ephedrine—Rash—Conjugated Estrogens—prostate cancer	0.000209	0.00127	CcSEcCtD
Ephedrine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000209	0.00127	CcSEcCtD
Ephedrine—Arrhythmia—Capecitabine—prostate cancer	0.000208	0.00126	CcSEcCtD
Ephedrine—Headache—Conjugated Estrogens—prostate cancer	0.000208	0.00126	CcSEcCtD
Ephedrine—Confusional state—Etoposide—prostate cancer	0.000208	0.00126	CcSEcCtD
Ephedrine—Hallucination—Prednisone—prostate cancer	0.000207	0.00125	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP2E1—prostate cancer	0.000205	0.0472	CrCbGaD
Ephedrine—SLC6A2—testis—prostate cancer	0.000205	0.0385	CbGeAlD
Ephedrine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000204	0.00124	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP1A1—prostate cancer	0.000203	0.0466	CrCbGaD
Ephedrine—Muscle spasms—Docetaxel—prostate cancer	0.000202	0.00122	CcSEcCtD
Ephedrine—Tachycardia—Etoposide—prostate cancer	0.000201	0.00122	CcSEcCtD
Ephedrine—Nausea—Goserelin—prostate cancer	0.000199	0.00121	CcSEcCtD
Ephedrine—Hyperhidrosis—Etoposide—prostate cancer	0.000199	0.00121	CcSEcCtD
Ephedrine—BCHE—bone marrow—prostate cancer	0.000198	0.0373	CbGeAlD
Ephedrine—Angina pectoris—Epirubicin—prostate cancer	0.000198	0.0012	CcSEcCtD
Ephedrine—Nausea—Conjugated Estrogens—prostate cancer	0.000197	0.0012	CcSEcCtD
Ephedrine—Selegiline—CYP2E1—prostate cancer	0.000197	0.0453	CrCbGaD
Ephedrine—Anorexia—Etoposide—prostate cancer	0.000196	0.00119	CcSEcCtD
Ephedrine—Body temperature increased—Mitoxantrone—prostate cancer	0.000196	0.00119	CcSEcCtD
Ephedrine—Muscle spasms—Capecitabine—prostate cancer	0.000195	0.00118	CcSEcCtD
Ephedrine—Selegiline—CYP2C19—prostate cancer	0.000195	0.0448	CrCbGaD
Ephedrine—Asthenia—Estradiol—prostate cancer	0.000191	0.00116	CcSEcCtD
Ephedrine—Tremor—Capecitabine—prostate cancer	0.00019	0.00115	CcSEcCtD
Ephedrine—Dysuria—Epirubicin—prostate cancer	0.00019	0.00115	CcSEcCtD
Ephedrine—Arrhythmia—Prednisone—prostate cancer	0.000186	0.00113	CcSEcCtD
Ephedrine—Palpitations—Docetaxel—prostate cancer	0.000185	0.00112	CcSEcCtD
Ephedrine—Dyspnoea—Etoposide—prostate cancer	0.000184	0.00111	CcSEcCtD
Ephedrine—Angina pectoris—Doxorubicin—prostate cancer	0.000183	0.00111	CcSEcCtD
Ephedrine—Vertigo—Capecitabine—prostate cancer	0.000183	0.00111	CcSEcCtD
Ephedrine—Hypertension—Docetaxel—prostate cancer	0.000181	0.0011	CcSEcCtD
Ephedrine—Palpitations—Capecitabine—prostate cancer	0.00018	0.00109	CcSEcCtD
Ephedrine—Decreased appetite—Etoposide—prostate cancer	0.000179	0.00109	CcSEcCtD
Ephedrine—Chest pain—Docetaxel—prostate cancer	0.000179	0.00108	CcSEcCtD
Ephedrine—Asthenia—Mitoxantrone—prostate cancer	0.000178	0.00108	CcSEcCtD
Ephedrine—Pain—Etoposide—prostate cancer	0.000176	0.00107	CcSEcCtD
Ephedrine—Dizziness—Estradiol—prostate cancer	0.000176	0.00107	CcSEcCtD
Ephedrine—Dysuria—Doxorubicin—prostate cancer	0.000176	0.00107	CcSEcCtD
Ephedrine—Hypertension—Capecitabine—prostate cancer	0.000175	0.00106	CcSEcCtD
Ephedrine—Sweating—Epirubicin—prostate cancer	0.000174	0.00105	CcSEcCtD
Ephedrine—Chest pain—Capecitabine—prostate cancer	0.000173	0.00105	CcSEcCtD
Ephedrine—Confusional state—Docetaxel—prostate cancer	0.000173	0.00105	CcSEcCtD
Ephedrine—Anxiety—Capecitabine—prostate cancer	0.000172	0.00105	CcSEcCtD
Ephedrine—Feeling abnormal—Etoposide—prostate cancer	0.00017	0.00103	CcSEcCtD
Ephedrine—BCHE—testis—prostate cancer	0.000169	0.0319	CbGeAlD
Ephedrine—Vomiting—Estradiol—prostate cancer	0.000169	0.00103	CcSEcCtD
Ephedrine—Rash—Estradiol—prostate cancer	0.000168	0.00102	CcSEcCtD
Ephedrine—Dermatitis—Estradiol—prostate cancer	0.000167	0.00102	CcSEcCtD
Ephedrine—Confusional state—Capecitabine—prostate cancer	0.000167	0.00101	CcSEcCtD
Ephedrine—Tachycardia—Docetaxel—prostate cancer	0.000167	0.00101	CcSEcCtD
Ephedrine—Headache—Estradiol—prostate cancer	0.000167	0.00101	CcSEcCtD
Ephedrine—Agitation—Prednisone—prostate cancer	0.000166	0.00101	CcSEcCtD
Ephedrine—Bradycardia—Epirubicin—prostate cancer	0.000166	0.001	CcSEcCtD
Ephedrine—Anorexia—Docetaxel—prostate cancer	0.000163	0.00099	CcSEcCtD
Ephedrine—Body temperature increased—Etoposide—prostate cancer	0.000163	0.000988	CcSEcCtD
Ephedrine—Vertigo—Prednisone—prostate cancer	0.000163	0.000986	CcSEcCtD
Ephedrine—Tachycardia—Capecitabine—prostate cancer	0.000162	0.000981	CcSEcCtD
Ephedrine—Sweating—Doxorubicin—prostate cancer	0.000161	0.000974	CcSEcCtD
Ephedrine—Hyperhidrosis—Capecitabine—prostate cancer	0.00016	0.000972	CcSEcCtD
Ephedrine—Anorexia—Capecitabine—prostate cancer	0.000158	0.000959	CcSEcCtD
Ephedrine—Nausea—Estradiol—prostate cancer	0.000158	0.000958	CcSEcCtD
Ephedrine—Vomiting—Mitoxantrone—prostate cancer	0.000158	0.000955	CcSEcCtD
Ephedrine—Hypertension—Prednisone—prostate cancer	0.000156	0.000948	CcSEcCtD
Ephedrine—Rash—Mitoxantrone—prostate cancer	0.000156	0.000947	CcSEcCtD
Ephedrine—Dermatitis—Mitoxantrone—prostate cancer	0.000156	0.000946	CcSEcCtD
Ephedrine—Headache—Mitoxantrone—prostate cancer	0.000155	0.000941	CcSEcCtD
Ephedrine—Insomnia—Docetaxel—prostate cancer	0.000155	0.000939	CcSEcCtD
Ephedrine—Anxiety—Prednisone—prostate cancer	0.000154	0.000931	CcSEcCtD
Ephedrine—Bradycardia—Doxorubicin—prostate cancer	0.000153	0.000929	CcSEcCtD
Ephedrine—Dyspnoea—Docetaxel—prostate cancer	0.000153	0.000926	CcSEcCtD
Ephedrine—Dyspepsia—Docetaxel—prostate cancer	0.000151	0.000914	CcSEcCtD
Ephedrine—Insomnia—Capecitabine—prostate cancer	0.00015	0.000909	CcSEcCtD
Ephedrine—Decreased appetite—Docetaxel—prostate cancer	0.000149	0.000903	CcSEcCtD
Ephedrine—SLC6A2—lymph node—prostate cancer	0.000149	0.0279	CbGeAlD
Ephedrine—Atomoxetine—CYP2C19—prostate cancer	0.000148	0.034	CrCbGaD
Ephedrine—Asthenia—Etoposide—prostate cancer	0.000148	0.000897	CcSEcCtD
Ephedrine—Dyspnoea—Capecitabine—prostate cancer	0.000148	0.000897	CcSEcCtD
Ephedrine—Nausea—Mitoxantrone—prostate cancer	0.000147	0.000892	CcSEcCtD
Ephedrine—Pain—Docetaxel—prostate cancer	0.000146	0.000888	CcSEcCtD
Ephedrine—Dyspepsia—Capecitabine—prostate cancer	0.000146	0.000885	CcSEcCtD
Ephedrine—Arrhythmia—Epirubicin—prostate cancer	0.000145	0.000881	CcSEcCtD
Ephedrine—Tachycardia—Prednisone—prostate cancer	0.000144	0.000874	CcSEcCtD
Ephedrine—Decreased appetite—Capecitabine—prostate cancer	0.000144	0.000874	CcSEcCtD
Ephedrine—Hyperhidrosis—Prednisone—prostate cancer	0.000143	0.000866	CcSEcCtD
Ephedrine—Pain—Capecitabine—prostate cancer	0.000142	0.00086	CcSEcCtD
Ephedrine—Feeling abnormal—Docetaxel—prostate cancer	0.000141	0.000856	CcSEcCtD
Ephedrine—Anorexia—Prednisone—prostate cancer	0.000141	0.000854	CcSEcCtD
Ephedrine—Tension—Epirubicin—prostate cancer	0.000139	0.000842	CcSEcCtD
Ephedrine—Nervousness—Epirubicin—prostate cancer	0.000137	0.000834	CcSEcCtD
Ephedrine—Feeling abnormal—Capecitabine—prostate cancer	0.000137	0.000829	CcSEcCtD
Ephedrine—Dizziness—Etoposide—prostate cancer	0.000136	0.000826	CcSEcCtD
Ephedrine—Muscle spasms—Epirubicin—prostate cancer	0.000136	0.000825	CcSEcCtD
Ephedrine—Body temperature increased—Docetaxel—prostate cancer	0.000135	0.000821	CcSEcCtD
Ephedrine—Arrhythmia—Doxorubicin—prostate cancer	0.000134	0.000815	CcSEcCtD
Ephedrine—Insomnia—Prednisone—prostate cancer	0.000134	0.00081	CcSEcCtD
Ephedrine—Body temperature increased—Capecitabine—prostate cancer	0.000131	0.000795	CcSEcCtD
Ephedrine—Vomiting—Etoposide—prostate cancer	0.000131	0.000795	CcSEcCtD
Ephedrine—Agitation—Epirubicin—prostate cancer	0.00013	0.000789	CcSEcCtD
Ephedrine—Dyspepsia—Prednisone—prostate cancer	0.00013	0.000788	CcSEcCtD
Ephedrine—Rash—Etoposide—prostate cancer	0.00013	0.000788	CcSEcCtD
Ephedrine—Dermatitis—Etoposide—prostate cancer	0.00013	0.000787	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP3A4—prostate cancer	0.000129	0.0297	CrCbGaD
Ephedrine—Headache—Etoposide—prostate cancer	0.000129	0.000783	CcSEcCtD
Ephedrine—Tension—Doxorubicin—prostate cancer	0.000129	0.000779	CcSEcCtD
Ephedrine—Decreased appetite—Prednisone—prostate cancer	0.000128	0.000779	CcSEcCtD
Ephedrine—Nervousness—Doxorubicin—prostate cancer	0.000127	0.000771	CcSEcCtD
Ephedrine—Vertigo—Epirubicin—prostate cancer	0.000127	0.000771	CcSEcCtD
Ephedrine—Muscle spasms—Doxorubicin—prostate cancer	0.000126	0.000764	CcSEcCtD
Ephedrine—Palpitations—Epirubicin—prostate cancer	0.000125	0.000759	CcSEcCtD
Ephedrine—Selegiline—CYP3A4—prostate cancer	0.000124	0.0285	CrCbGaD
Ephedrine—Asthenia—Docetaxel—prostate cancer	0.000123	0.000745	CcSEcCtD
Ephedrine—BCHE—lymph node—prostate cancer	0.000123	0.0231	CbGeAlD
Ephedrine—Nausea—Etoposide—prostate cancer	0.000122	0.000742	CcSEcCtD
Ephedrine—Hypertension—Epirubicin—prostate cancer	0.000122	0.000741	CcSEcCtD
Ephedrine—Feeling abnormal—Prednisone—prostate cancer	0.000122	0.000738	CcSEcCtD
Ephedrine—Chest pain—Epirubicin—prostate cancer	0.00012	0.000731	CcSEcCtD
Ephedrine—Agitation—Doxorubicin—prostate cancer	0.00012	0.00073	CcSEcCtD
Ephedrine—Anxiety—Epirubicin—prostate cancer	0.00012	0.000728	CcSEcCtD
Ephedrine—Asthenia—Capecitabine—prostate cancer	0.000119	0.000721	CcSEcCtD
Ephedrine—Vertigo—Doxorubicin—prostate cancer	0.000118	0.000714	CcSEcCtD
Ephedrine—Body temperature increased—Prednisone—prostate cancer	0.000117	0.000708	CcSEcCtD
Ephedrine—Confusional state—Epirubicin—prostate cancer	0.000116	0.000706	CcSEcCtD
Ephedrine—Palpitations—Doxorubicin—prostate cancer	0.000116	0.000702	CcSEcCtD
Ephedrine—Dizziness—Docetaxel—prostate cancer	0.000113	0.000687	CcSEcCtD
Ephedrine—Hypertension—Doxorubicin—prostate cancer	0.000113	0.000686	CcSEcCtD
Ephedrine—Tachycardia—Epirubicin—prostate cancer	0.000113	0.000684	CcSEcCtD
Ephedrine—Hyperhidrosis—Epirubicin—prostate cancer	0.000112	0.000677	CcSEcCtD
Ephedrine—Chest pain—Doxorubicin—prostate cancer	0.000111	0.000676	CcSEcCtD
Ephedrine—Anxiety—Doxorubicin—prostate cancer	0.000111	0.000674	CcSEcCtD
Ephedrine—Anorexia—Epirubicin—prostate cancer	0.00011	0.000668	CcSEcCtD
Ephedrine—Dizziness—Capecitabine—prostate cancer	0.00011	0.000665	CcSEcCtD
Ephedrine—Vomiting—Docetaxel—prostate cancer	0.000109	0.00066	CcSEcCtD
Ephedrine—Rash—Docetaxel—prostate cancer	0.000108	0.000655	CcSEcCtD
Ephedrine—Dermatitis—Docetaxel—prostate cancer	0.000108	0.000654	CcSEcCtD
Ephedrine—Confusional state—Doxorubicin—prostate cancer	0.000108	0.000654	CcSEcCtD
Ephedrine—Headache—Docetaxel—prostate cancer	0.000107	0.000651	CcSEcCtD
Ephedrine—Asthenia—Prednisone—prostate cancer	0.000106	0.000643	CcSEcCtD
Ephedrine—Vomiting—Capecitabine—prostate cancer	0.000105	0.000639	CcSEcCtD
Ephedrine—Rash—Capecitabine—prostate cancer	0.000105	0.000634	CcSEcCtD
Ephedrine—Insomnia—Epirubicin—prostate cancer	0.000104	0.000634	CcSEcCtD
Ephedrine—Dermatitis—Capecitabine—prostate cancer	0.000104	0.000633	CcSEcCtD
Ephedrine—Tachycardia—Doxorubicin—prostate cancer	0.000104	0.000633	CcSEcCtD
Ephedrine—Headache—Capecitabine—prostate cancer	0.000104	0.00063	CcSEcCtD
Ephedrine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000103	0.000627	CcSEcCtD
Ephedrine—Dyspnoea—Epirubicin—prostate cancer	0.000103	0.000625	CcSEcCtD
Ephedrine—Anorexia—Doxorubicin—prostate cancer	0.000102	0.000618	CcSEcCtD
Ephedrine—Nausea—Docetaxel—prostate cancer	0.000102	0.000617	CcSEcCtD
Ephedrine—Dyspepsia—Epirubicin—prostate cancer	0.000102	0.000617	CcSEcCtD
Ephedrine—Decreased appetite—Epirubicin—prostate cancer	0.0001	0.000609	CcSEcCtD
Ephedrine—Pain—Epirubicin—prostate cancer	9.88e-05	0.000599	CcSEcCtD
Ephedrine—Nausea—Capecitabine—prostate cancer	9.85e-05	0.000597	CcSEcCtD
Ephedrine—Dizziness—Prednisone—prostate cancer	9.77e-05	0.000592	CcSEcCtD
Ephedrine—Insomnia—Doxorubicin—prostate cancer	9.67e-05	0.000586	CcSEcCtD
Ephedrine—Dyspnoea—Doxorubicin—prostate cancer	9.53e-05	0.000578	CcSEcCtD
Ephedrine—Feeling abnormal—Epirubicin—prostate cancer	9.52e-05	0.000577	CcSEcCtD
Ephedrine—Dyspepsia—Doxorubicin—prostate cancer	9.41e-05	0.000571	CcSEcCtD
Ephedrine—Atomoxetine—CYP3A4—prostate cancer	9.41e-05	0.0216	CrCbGaD
Ephedrine—Vomiting—Prednisone—prostate cancer	9.39e-05	0.00057	CcSEcCtD
Ephedrine—Rash—Prednisone—prostate cancer	9.31e-05	0.000565	CcSEcCtD
Ephedrine—Dermatitis—Prednisone—prostate cancer	9.3e-05	0.000564	CcSEcCtD
Ephedrine—Decreased appetite—Doxorubicin—prostate cancer	9.29e-05	0.000563	CcSEcCtD
Ephedrine—Headache—Prednisone—prostate cancer	9.25e-05	0.000561	CcSEcCtD
Ephedrine—Pain—Doxorubicin—prostate cancer	9.14e-05	0.000554	CcSEcCtD
Ephedrine—Body temperature increased—Epirubicin—prostate cancer	9.13e-05	0.000554	CcSEcCtD
Ephedrine—Feeling abnormal—Doxorubicin—prostate cancer	8.81e-05	0.000534	CcSEcCtD
Ephedrine—Nausea—Prednisone—prostate cancer	8.77e-05	0.000532	CcSEcCtD
Ephedrine—Body temperature increased—Doxorubicin—prostate cancer	8.45e-05	0.000512	CcSEcCtD
Ephedrine—Asthenia—Epirubicin—prostate cancer	8.29e-05	0.000503	CcSEcCtD
Ephedrine—Asthenia—Doxorubicin—prostate cancer	7.67e-05	0.000465	CcSEcCtD
Ephedrine—Dizziness—Epirubicin—prostate cancer	7.64e-05	0.000463	CcSEcCtD
Ephedrine—Vomiting—Epirubicin—prostate cancer	7.34e-05	0.000445	CcSEcCtD
Ephedrine—Rash—Epirubicin—prostate cancer	7.28e-05	0.000442	CcSEcCtD
Ephedrine—Dermatitis—Epirubicin—prostate cancer	7.28e-05	0.000441	CcSEcCtD
Ephedrine—Headache—Epirubicin—prostate cancer	7.24e-05	0.000439	CcSEcCtD
Ephedrine—Dizziness—Doxorubicin—prostate cancer	7.07e-05	0.000429	CcSEcCtD
Ephedrine—Nausea—Epirubicin—prostate cancer	6.86e-05	0.000416	CcSEcCtD
Ephedrine—Vomiting—Doxorubicin—prostate cancer	6.8e-05	0.000412	CcSEcCtD
Ephedrine—Rash—Doxorubicin—prostate cancer	6.74e-05	0.000409	CcSEcCtD
Ephedrine—Dermatitis—Doxorubicin—prostate cancer	6.73e-05	0.000408	CcSEcCtD
Ephedrine—Headache—Doxorubicin—prostate cancer	6.7e-05	0.000406	CcSEcCtD
Ephedrine—Nausea—Doxorubicin—prostate cancer	6.35e-05	0.000385	CcSEcCtD
Ephedrine—ADRA1A—Signaling by GPCR—ADRB2—prostate cancer	1.54e-05	0.000158	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GGT1—prostate cancer	1.53e-05	0.000158	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—P4HB—prostate cancer	1.52e-05	0.000157	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CX3CL1—prostate cancer	1.52e-05	0.000157	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ITPR1—prostate cancer	1.51e-05	0.000156	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NCOA1—prostate cancer	1.51e-05	0.000155	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CXCL8—prostate cancer	1.5e-05	0.000155	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—VAV3—prostate cancer	1.5e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIST1H2BG—prostate cancer	1.5e-05	0.000154	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.49e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTHLH—prostate cancer	1.49e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFBR1—prostate cancer	1.49e-05	0.000153	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP19A1—prostate cancer	1.48e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDE4D—prostate cancer	1.48e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GRB7—prostate cancer	1.48e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKR1C3—prostate cancer	1.46e-05	0.000151	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRKACB—prostate cancer	1.45e-05	0.00015	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ITPR1—prostate cancer	1.45e-05	0.00015	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIST1H4H—prostate cancer	1.45e-05	0.000149	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL8—prostate cancer	1.44e-05	0.000149	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	1.44e-05	0.000149	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—RXRA—prostate cancer	1.43e-05	0.000148	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TYMS—prostate cancer	1.43e-05	0.000148	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—THBS1—prostate cancer	1.42e-05	0.000146	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PPP3CA—prostate cancer	1.42e-05	0.000146	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTM1—prostate cancer	1.41e-05	0.000146	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GNG5—prostate cancer	1.41e-05	0.000146	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ANXA1—prostate cancer	1.4e-05	0.000144	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.39e-05	0.000144	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—LPL—prostate cancer	1.39e-05	0.000143	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CTNNB1—prostate cancer	1.38e-05	0.000143	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—COMT—prostate cancer	1.38e-05	0.000142	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTP1—prostate cancer	1.37e-05	0.000142	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRKCZ—prostate cancer	1.37e-05	0.000142	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ITPR1—prostate cancer	1.35e-05	0.000139	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CG—prostate cancer	1.34e-05	0.000138	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP1A1—prostate cancer	1.34e-05	0.000138	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CXCL8—prostate cancer	1.34e-05	0.000138	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ERCC2—prostate cancer	1.33e-05	0.000137	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.33e-05	0.000137	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGFR4—prostate cancer	1.32e-05	0.000137	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PARP1—prostate cancer	1.32e-05	0.000137	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CALCA—prostate cancer	1.31e-05	0.000135	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL12—prostate cancer	1.28e-05	0.000132	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TYMS—prostate cancer	1.28e-05	0.000132	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—prostate cancer	1.26e-05	0.00013	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTHFR—prostate cancer	1.25e-05	0.000129	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—LPL—prostate cancer	1.24e-05	0.000128	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	1.23e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTHLH—prostate cancer	1.23e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFBR1—prostate cancer	1.23e-05	0.000127	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARA—prostate cancer	1.23e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CG—prostate cancer	1.22e-05	0.000126	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKR1C3—prostate cancer	1.21e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP9—prostate cancer	1.2e-05	0.000124	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKACB—prostate cancer	1.2e-05	0.000124	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP1A1—prostate cancer	1.2e-05	0.000123	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ERCC2—prostate cancer	1.19e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CD—prostate cancer	1.18e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PPP3CA—prostate cancer	1.17e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—THBS1—prostate cancer	1.17e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRKCQ—prostate cancer	1.17e-05	0.00012	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NGFR—prostate cancer	1.17e-05	0.00012	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ANXA1—prostate cancer	1.16e-05	0.000119	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAV1—prostate cancer	1.15e-05	0.000119	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAP3K7—prostate cancer	1.15e-05	0.000119	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKCZ—prostate cancer	1.13e-05	0.000117	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTHFR—prostate cancer	1.11e-05	0.000115	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—prostate cancer	1.11e-05	0.000114	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGF10—prostate cancer	1.11e-05	0.000114	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.1e-05	0.000114	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGFR4—prostate cancer	1.1e-05	0.000113	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PARP1—prostate cancer	1.1e-05	0.000113	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARA—prostate cancer	1.09e-05	0.000113	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CALCA—prostate cancer	1.08e-05	0.000112	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	1.08e-05	0.000112	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	1.08e-05	0.000111	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	1.07e-05	0.00011	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VAV3—prostate cancer	1.07e-05	0.00011	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL12—prostate cancer	1.06e-05	0.000109	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	1.05e-05	0.000109	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CG—prostate cancer	1.05e-05	0.000108	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ITPR1—prostate cancer	1.04e-05	0.000107	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAV1—prostate cancer	1.03e-05	0.000106	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	1.03e-05	0.000106	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CG—prostate cancer	1.01e-05	0.000104	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP9—prostate cancer	9.95e-06	0.000103	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—INS—prostate cancer	9.94e-06	0.000103	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1R—prostate cancer	9.92e-06	0.000102	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	9.87e-06	0.000102	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.82e-06	0.000101	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—JAK2—prostate cancer	9.82e-06	0.000101	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CD—prostate cancer	9.75e-06	0.000101	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CREBBP—prostate cancer	9.74e-06	0.0001	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NGFR—prostate cancer	9.65e-06	9.95e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKCQ—prostate cancer	9.65e-06	9.95e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAP3K7—prostate cancer	9.53e-06	9.84e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LPL—prostate cancer	9.51e-06	9.81e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2—prostate cancer	9.43e-06	9.73e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	9.42e-06	9.72e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CG—prostate cancer	9.37e-06	9.67e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	9.33e-06	9.63e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CD—prostate cancer	9.23e-06	9.53e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ITGB3—prostate cancer	9.18e-06	9.47e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF10—prostate cancer	9.16e-06	9.46e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADRB2—prostate cancer	9.07e-06	9.36e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	8.96e-06	9.25e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—JAK2—prostate cancer	8.95e-06	9.23e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAP2K1—prostate cancer	8.91e-06	9.2e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB3—prostate cancer	8.91e-06	9.19e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGFR2—prostate cancer	8.89e-06	9.18e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—INS—prostate cancer	8.87e-06	9.15e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CD—prostate cancer	8.85e-06	9.13e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VAV3—prostate cancer	8.84e-06	9.13e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFBR2—prostate cancer	8.72e-06	9e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NOS3—prostate cancer	8.72e-06	8.99e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CREBBP—prostate cancer	8.68e-06	8.96e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ITPR1—prostate cancer	8.58e-06	8.85e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2—prostate cancer	8.57e-06	8.84e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TERT—prostate cancer	8.54e-06	8.81e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CB—prostate cancer	8.5e-06	8.77e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CD—prostate cancer	8.23e-06	8.5e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1R—prostate cancer	8.2e-06	8.46e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL8—prostate cancer	8.16e-06	8.43e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HIF1A—prostate cancer	8.16e-06	8.42e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—JAK2—prostate cancer	8.12e-06	8.38e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CB—prostate cancer	8.05e-06	8.3e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—prostate cancer	7.97e-06	8.23e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LEP—prostate cancer	7.97e-06	8.22e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CAV1—prostate cancer	7.89e-06	8.15e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LPL—prostate cancer	7.86e-06	8.11e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KDR—prostate cancer	7.81e-06	8.06e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2—prostate cancer	7.8e-06	8.05e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDGFRB—prostate cancer	7.79e-06	8.04e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NOS3—prostate cancer	7.78e-06	8.02e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CB—prostate cancer	7.72e-06	7.96e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ESR1—prostate cancer	7.61e-06	7.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ITGB3—prostate cancer	7.59e-06	7.84e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BAD—prostate cancer	7.43e-06	7.66e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL8—prostate cancer	7.41e-06	7.65e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB3—prostate cancer	7.37e-06	7.6e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGFR2—prostate cancer	7.35e-06	7.59e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	7.19e-06	7.42e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APC—prostate cancer	7.19e-06	7.42e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CB—prostate cancer	7.18e-06	7.41e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—prostate cancer	7.11e-06	7.34e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGF—prostate cancer	7.11e-06	7.34e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IRS1—prostate cancer	7.11e-06	7.34e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2—prostate cancer	7.09e-06	7.31e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TERT—prostate cancer	7.06e-06	7.29e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTEN—prostate cancer	6.95e-06	7.17e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GSK3B—prostate cancer	6.9e-06	7.12e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—INS—prostate cancer	6.81e-06	7.02e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIF1A—prostate cancer	6.75e-06	6.97e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CREBBP—prostate cancer	6.67e-06	6.88e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—EP300—prostate cancer	6.63e-06	6.84e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LEP—prostate cancer	6.59e-06	6.8e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1—prostate cancer	6.58e-06	6.79e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EGFR—prostate cancer	6.55e-06	6.76e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CAV1—prostate cancer	6.53e-06	6.74e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KDR—prostate cancer	6.46e-06	6.66e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	6.36e-06	6.57e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	6.32e-06	6.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ESR1—prostate cancer	6.29e-06	6.49e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	6.26e-06	6.46e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	6.25e-06	6.45e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTEN—prostate cancer	6.2e-06	6.4e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KRAS—prostate cancer	6.19e-06	6.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BAD—prostate cancer	6.14e-06	6.34e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGF2—prostate cancer	6.05e-06	6.25e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOS3—prostate cancer	5.97e-06	6.16e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APC—prostate cancer	5.95e-06	6.14e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CG—prostate cancer	5.95e-06	6.14e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—EP300—prostate cancer	5.91e-06	6.1e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IRS1—prostate cancer	5.88e-06	6.07e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGF—prostate cancer	5.88e-06	6.07e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JAK2—prostate cancer	5.8e-06	5.99e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GSK3B—prostate cancer	5.71e-06	5.89e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	5.69e-06	5.87e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MDM2—prostate cancer	5.66e-06	5.84e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—INS—prostate cancer	5.63e-06	5.81e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB2—prostate cancer	5.58e-06	5.76e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CREBBP—prostate cancer	5.51e-06	5.69e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	5.51e-06	5.69e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1—prostate cancer	5.45e-06	5.62e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EGFR—prostate cancer	5.42e-06	5.59e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL8—prostate cancer	5.3e-06	5.46e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAP2K1—prostate cancer	5.26e-06	5.43e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CD—prostate cancer	5.23e-06	5.4e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—prostate cancer	5.18e-06	5.34e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SERPINE1—prostate cancer	5.17e-06	5.34e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	5.17e-06	5.34e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KRAS—prostate cancer	5.12e-06	5.28e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	5.12e-06	5.28e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—prostate cancer	5.07e-06	5.23e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2—prostate cancer	5.06e-06	5.22e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—prostate cancer	5.04e-06	5.2e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF2—prostate cancer	5.01e-06	5.17e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOS3—prostate cancer	4.94e-06	5.1e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCND1—prostate cancer	4.93e-06	5.09e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CA—prostate cancer	4.9e-06	5.06e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	4.89e-06	5.04e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JAK2—prostate cancer	4.8e-06	4.95e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—prostate cancer	4.79e-06	4.94e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	4.77e-06	4.92e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTEN—prostate cancer	4.76e-06	4.91e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	4.7e-06	4.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MDM2—prostate cancer	4.68e-06	4.83e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—prostate cancer	4.65e-06	4.79e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	4.62e-06	4.77e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	4.56e-06	4.7e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EP300—prostate cancer	4.54e-06	4.69e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SRC—prostate cancer	4.42e-06	4.56e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	4.38e-06	4.52e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CA—prostate cancer	4.38e-06	4.52e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—prostate cancer	4.3e-06	4.44e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	4.28e-06	4.41e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—prostate cancer	4.26e-06	4.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	4.23e-06	4.37e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—prostate cancer	4.19e-06	4.33e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2—prostate cancer	4.19e-06	4.32e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—prostate cancer	4.16e-06	4.3e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCND1—prostate cancer	4.08e-06	4.21e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	4.04e-06	4.17e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—prostate cancer	4.01e-06	4.13e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	3.96e-06	4.09e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—prostate cancer	3.96e-06	4.08e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	3.95e-06	4.07e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—prostate cancer	3.95e-06	4.07e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	3.94e-06	4.06e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGFR—prostate cancer	3.87e-06	3.99e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	3.84e-06	3.97e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EP300—prostate cancer	3.76e-06	3.88e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KRAS—prostate cancer	3.66e-06	3.77e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SRC—prostate cancer	3.65e-06	3.77e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—prostate cancer	3.57e-06	3.69e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	3.56e-06	3.67e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	3.52e-06	3.63e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	3.36e-06	3.47e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—prostate cancer	3.27e-06	3.38e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	3.26e-06	3.37e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—prostate cancer	3.25e-06	3.35e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	3.2e-06	3.3e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	3.02e-06	3.12e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—prostate cancer	2.97e-06	3.07e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	2.78e-06	2.87e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—prostate cancer	2.74e-06	2.83e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—prostate cancer	2.69e-06	2.77e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—prostate cancer	2.46e-06	2.54e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	2.27e-06	2.34e-05	CbGpPWpGaD
